Amgen is laying off 22 staffers from its Horizon Therapeutics site in Rockville, Maryland, effective by early May 2026, as per Maryland WARN alert.
The layoffs are part of organizational changes to align operations with Amgen's research strategy following the 2023 $27.8 billion acquisition of Horizon.
Amgen spokesperson confirmed the cuts affect roles at the Rockville R&D location and support is being provided to impacted employees.
No recent reports confirm Vertex Pharmaceuticals trimming its team in the Fierce Biotech Layoff Tracker 2026; focus is on Amgen, Evotec (800 layoffs), and others.
Other 2026 biotech layoffs include Evotec planning 800 cuts, f5 Therapeutics shutting down (up to 10 employees), and Alltrna reducing by 19 people.